(Q38945158)

7 September 2017

title

CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo (English)

1 reference

7 September 2017

1

1 reference

7 September 2017

4

Andreas Lundqvist

1 reference

7 September 2017

Veronika Kremer

2

1 reference

7 September 2017

Richard Childs

series ordinal

3

1 reference

7 September 2017

publication date

26 October 2014

1 reference

Cancer Immunology, Immunotherapy

7 September 2017

published in

1 reference

7 September 2017

volume

64

1 reference

7 September 2017

issue

2

1 reference

7 September 2017

page(s)

225-235

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-014-1629-5

7 September 2017

exact match

0 references

cites work

IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Tumor‐localization by adoptively transferred, interleukin‐2‐activated NK cells leads to destruction of well‐established lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

CXCR3 ligands: redundant, collaborative and antagonistic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Biomolecular Network Reconstruction Identifies T-Cell Homing Factors Associated With Survival in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

CXCL10 promotes invasion-related properties in human colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

A dual role for tumor-derived chemokine RANTES (CCL5).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Expression of chemokines and chemokine receptors in human colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

IL-2 and IL-12 alter NK cell responsiveness to IFN-gamma-inducible protein 10 by down-regulating CXCR3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

GMP-compliant, large-scale expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

1,25-Dihydroxyvitamin D₃ enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-014-1629-5

10.1007/S00262-014-1629-5

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1007725035

0 references

1 reference